TY - JOUR AU - Sarabia de Ardanaz, Luis AU - Andreu Ubero, José María AU - Navidad Fuentes, Miriam AU - Ferrer González, Miguel Ángel AU - Ruiz del Valle, Víctor AU - Salcedo Bellido, Inmaculada AU - Barrios Rodríguez, Rocío AU - Cáliz Cáliz, Antonio Rafael AU - Requena Méndez, María del Pilar PY - 2021 UR - http://hdl.handle.net/10481/70202 AB - Tocilizumab (TCZ) has been administered in SARS-CoV-2 pneumonia but the factors associated with mortality before and after treatment remain unclear. Cox regression models were used to estimate the predictors of time to death in a cohort of... LA - eng PB - Frontiers Research Foundation KW - COVID-19 KW - Immunosupression KW - Tocilizumab KW - Mortality KW - Risk factor KW - Platelet TI - Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment DO - 10.3389/fphar.2021.620187 ER -